Collaborative Care for Depression and Diabetic Retinopathy in African Americans

Completed · Not applicable

Conditions studied: Diabetic Retinopathy

In brief

In this feasibility/pilot study, we will develop, refine, and evaluate the feasibility of a novel mental health/ophthalmologic intervention called, "Collaborative Care for Depression and Diabetic Retinopathy" (CC-DDR), which aims to treat depression and lower HbA1C in older African Americans with mild-to-moderate diabetic retinopathy (DR) and comorbid depression.

Key facts

Study ID

NCT02121340

Run by

Thomas Jefferson University

People needed

40

Starts

2014-05-01

Expected to finish

2018-12-01

Last updated by the study team

2019-02-21

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• African-American race
• age ≥ 65 years
• type 2 diabetes
• mild or moderate nonproliferative DR with or without macular edema
• depressive symptoms (i.e., Patient Health Questionnaire-9 score ≥5)
• HbA1C ≥ 7.0%

You may not qualify if…

• treated proliferative DR
• global cognitive impairment (i.e., Mini Mental Status score ≤ 20)
• psychiatric diagnosis other than depression
• treatment for depression started in the previous 3 months
• life expectancy under 2 years

Where it is running

• Thomas Jefferson University — Philadelphia, Pennsylvania, United States
• Wills Eye Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.